trending Market Intelligence /marketintelligence/en/news-insights/trending/IMUO4n_KFNvUTWiYiS0uRQ2 content esgSubNav
In This List

Shire appoints chief scientific, medical officers

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Shire appoints chief scientific, medical officers

Shire plc appointed Andreas Busch executive vice president, head of research and development and chief scientific officer.

Howard Mayer, who is serving as interim head of R&D, was appointed chief medical officer.

Both appointments are effective January 2018.

Busch previously served as head of drug discovery of Bayer AG's pharmaceutical division.